Abstract
AbstractAtopic dermatitis (AD) is a common dermatologic ailment with a large variety of treatment options ranging from topical to systemic medications. First‐line treatment for AD often involves topical therapy using agents such as emollients, topical corticosteroids, phosphodiesterase‐4 (PDE4) inhibitors, and calcineurin inhibitors. Despite these therapeutic options, there are numerous emerging topical therapies in the pipeline for AD. This review will discuss novel and emerging topical medications for AD including PDE4 inhibitors, janus kinase inhibitors, aryl hydrocarbon receptor modulators, and other miscellaneous agents.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
